Facet Syndrome of Lumbar Spine Clinical Trial
Official title:
High-Intensity Focused Ultrasound Ablation With the Neurolyser XR Device for the Treatment of Chronic Low Back Pain: a Prospective Randomized Double-Blind Sham-Controlled Multicenter Study
Verified date | September 2023 |
Source | FUSMobile Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Double arm pivotal study to evaluate the Neurolyser XR as a non-invasive treatment of axial chronic low back pain
Status | Active, not recruiting |
Enrollment | 90 |
Est. completion date | April 1, 2024 |
Est. primary completion date | April 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 85 Years |
Eligibility | Inclusion Criteria: 1. Age 50 to 85 years old, legally able and willing to participate in the study and all follow-up visits 2. Able and willing to complete the research questionnaires and to communicate with investigator and research team 3. Individual with current bilateral or unilateral low back pain of > 6 months duration 4. Individual whose back pain is alleviated by recumbency or comfortable sitting position 5. Individual presenting with a) a positive (>80% pain relief) to a previous, double, lumbar medial branch block (within the last 12 months) and/or b) with a positive (>70% pain relief lasting more than 6 months) to the most recent lumbar facet thermal radiofrequency denervation 6. Average low back pain score of 6 or higher in the last month (on 0-10 scale) with activity Exclusion Criteria: 1. Individuals who are pregnant or breastfeeding 2. Individuals younger than 50 or older than 85 years 3. BMI greater than 40, or individuals with at least one of the planned targets outside the Neurolyser XR treatment envelope as seen on treatment day on a lateral X-ray scan taken before the treatment. 4. Individuals presenting with neurological deficits (including lumbosacral radiculopathy but not solitary radicular pain) 5. Individuals with history of lumbar or lumbosacral spine surgery 6. Individuals who have had lumbar radiofrequency neurotomy in the past 6 months 7. Individuals with history of lumbar spine pathology that may increase procedural risk and/or influence symptoms and/or generate unrelated adverse event (per investigator's discretion) 8. Individuals presenting with any severe medical condition preventing them from participation (per investigator's discretion) (Example: inability to lay prone) 9. Individuals with extensive scarring of the skin and tissue overlying the treatment area 10. Individuals enrolled in or planned to be enrolled in another clinical trial during the duration of this research project 11. Any Individuals with an uncontrolled coagulopathy 12. Individuals with known osteoporosis with absolute risk of spinal fracture of > 10% over 10 years 13. Any Individuals with a history of malignant disease in the past five years or any individuals with clinical history suggestive of new/previously unknown malignancy and pathological pain who require further work up or is currently undergoing work up 14. Individuals with rheumatologic diseases causing spine pain that are currently receiving active treatment including steroids, disease modifying drugs, biological agents or immunosuppressants 15. Individuals known for concomitant psychiatric disorders, excluding compensated mood disorders 16. Individuals with first-degree family member already enrolled in this study 17. Individual who is scheduled for any interventional/surgical procedure within 6 months from the treatment date excluding trivial surgeries (e.g., cataract, carpal tunnel release) 18. Individuals diagnosed with co-morbid multifocal chronic pain (e.g. fibromyalgia, generalized osteoarthritis) 19. Individuals with other chronic pain that is 2 or more points higher on the NRS score than the participants low back pain 20. Individuals who have had a steroid injection within the last 2 months from date of enrollment at the location of the planned treatment 21. Any individuals with clinical or radiographic evidence of dynamic instability of the lumbar spine |
Country | Name | City | State |
---|---|---|---|
United States | Emory | Atlanta | Georgia |
United States | The Physicians Spine and Rehabilitation Specialist of GA | Atlanta | Georgia |
United States | Charlie Norwood VA Medical Center | Augusta | Georgia |
United States | University of Virginia Pain Management Center | Charlottesville | Virginia |
United States | Mayo University Jacksonville | Jacksonville | Florida |
United States | Univ of Miami Rehabilitation Medicine | Miami | Florida |
United States | Ainsworth Institute of Pain Management | New York | New York |
United States | Stamford Hospital | Stamford | Connecticut |
United States | Gershon Pain Specialists | Virginia Beach | Virginia |
United States | Center for Clinical Research | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
FUSMobile Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NRS | Change in average pain score as measured by a numeric rating scale from 0 (no pain) to 10, worst possible pain | Base line, 2 days 1, 2 & 4 weeks, 3 & 6 months after procedure | |
Primary | Procedure and Device Safety up to six months post procedure | Safety will be measured by the incidence and severity of treatment related adverse events | 6 months after procedure | |
Secondary | Oswestry Disability Index (ODI) | Low Back Pain Questionnaire (Range: 0% to 100%) | Time Frame: Base line, 1, & 4 weeks, 3 & 6 months after procedure | |
Secondary | Patient Global Impression of Change (PGIC) | Patient Global Impression of Change (Range: 1 to 7) | Time Frame: Base line, 1, & 4 weeks, 3 & 6 months after procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03770585 -
Fluoroscopy Guided Lumbar Facet Joint Injection Versus Ultrasound Guided Injection in Patients With Low Back Pain Due to Facet Syndrome
|
N/A | |
Active, not recruiting |
NCT04129034 -
Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT04893720 -
The SPINUS II Study: Spinal Fusion for Multilevel SPECT/CT Positive Lumbar Degeneration
|
||
Recruiting |
NCT06325631 -
Comparative Evaluation of the Results of Facet Joint Injections
|
N/A | |
Recruiting |
NCT03564418 -
Ultrasound-Guided Thermocoagulation of Medial Nerve Branch in Lumbar Facet Joints Pain.
|
N/A | |
Completed |
NCT04519541 -
RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT03871192 -
Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome
|
N/A |